Dataset Information

The Human Gut Microbiome and Recurrent Abdominal Pain in Children

ABSTRACT:

This project explores the nature of the human intestinal microbiome in healthy children and children with recurrent abdominal pain. The overall goal is to obtain a robust knowledge-base of the intestinal microbiome in children without evidence of pain or gastrointestinal disease, children with functional abdominal pain, and children with abdominal pain and changes in bowel habits (irritable bowel syndrome). Multiple strategies have been deployed to navigate and understand the nature of the intestinal microbiome in childhood. These strategies include 454 pyrosequencing-based strategies to sequence 16S rRNA genes and understand the detailed composition of microbes in healthy and disease groups. Microarray-based hybridization with the PhyloChip and quantitative real-time PCR (qPCR) probes are being applied as complementary strategies to gain an understanding of the intestinal microbiome from various perspectives. Data collected and analyzed during the HMP UH2 and UH3 Demo project, from a set of healthy and IBS children may enable the identification of core microbiomes in children in addition to variable components that may distinguish healthy from diseased pediatric states. We are currently analyzing the dataset for the presence of disease-specific signatures in the human microbiome, and correlating these microbial signatures with pediatric health or IBS disease status. This study explores the nature of core and variable human microbiomes in pre-adolescent healthy children and children with recurrent abdominal pain.

PROVIDER: phs000265.v3.p1 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Publications

Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome.

Saulnier Delphine M DM Riehle Kevin K Mistretta Toni-Ann TA Diaz Maria-Alejandra MA Mandal Debasmita D Raza Sabeen S Weidler Erica M EM Qin Xiang X Coarfa Cristian C Milosavljevic Aleksandar A Petrosino Joseph F JF Highlander Sarah S Gibbs Richard R Lynch Susan V SV Shulman Robert J RJ Versalovic James J

Gastroenterology 20110708 5

<h4>Background & aims</h4>The intestinal microbiomes of healthy children and pediatric patients with irritable bowel syndrome (IBS) are not well defined. Studies in adults have indicated that the gastrointestinal microbiota could be involved in IBS.<h4>Methods</h4>We analyzed 71 samples from 22 children with IBS (pediatric Rome III criteria) and 22 healthy children, ages 7-12 years, by 16S ribosomal RNA gene sequencing, with an average of 54,287 reads/stool sample (average 454 read length = 503 ...[more]

PMID: 21741921

Publication: 1/2

Similar Datasets

Project description:<p>Irritable bowel syndrome (IBS) is one of the functional gastrointestinal disorders characterized by chronic and/or recurrent symptoms of abdominal pain and irregular defecation. Changed gut microbiota has been proposed to mediate IBS; however, contradictory results exist, and IBS-specific microbiota, metabolites, and their interactions remain poorly understood. To address this issue, we performed metabolomic and metagenomic profiling of stool and serum samples based on discovery (<em>n</em> = 330) and validation (<em>n</em> = 101) cohorts. Fecal metagenomic data showed moderate dysbiosis compared with other diseases, in contrast, serum metabolites showed significant differences with greater power to distinguish IBS patients from healthy controls. Specifically, 726 differentially abundant serum metabolites were identified, including a cluster of fatty acyl-CoAs enriched in IBS. We further identified 522 robust associations between differentially abundant gut bacteria and fecal metabolites, of which three species including <em>Odoribacter splanchnicus</em>, <em>Escherichia coli</em>, and <em>Ruminococcus gnavus</em> were strongly associated with the low abundance of dihydropteroic acid. Moreover, dysregulated tryptophan/serotonin metabolism was found to be correlated with the severity of IBS depression in both fecal and serum metabolomes, characterized by a shift in tryptophan metabolism towards kynurenine production. Collectively, our study revealed serum/fecal metabolome alterations and their relationship with gut microbiome, highlighted the massive alterations of serum metabolites, which empower to recognize IBS patients, suggested potential roles of metabolic dysregulation in IBS pathogenesis, and offered new clues to understand IBS depression comorbidity. Our study provided a valuable resource for future studies, and would facilitate potential clinical applications of IBS featured microbiota and/or metabolites.</p>

Dataset Information

The Human Gut Microbiome and Recurrent Abdominal Pain in Children

Publications

Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure